chrisvoncsefalvay/vaers-outcomes huggingface dataset:
16 hrs post 2nd COVID vaccination injection I experienced the following symptoms: severe aches and pains in joints, chills-cold hands,feet, lethargy, slight nausea, diarrhea. Symptoms subsided over the following 24 hours. Joint aches continue
This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 75-year-old male patient who received SHINGRIX (batch number Z9RR4, expiry date 15th November 2020) for prophylaxis. Concomitant products included SHINGRIX. On 19th June 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 19th June 2018, several hours after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site erythema, injection site pain and lethargy. The patient was treated with BENADRYL. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema, injection site pain and lethargy were not recovered/not resolved. The reporter considered the extensive swelling of vaccinated limb, injection site erythema, injection site pain and lethargy to be almost certainly related to SHINGRIX. Additional information was received as follows: The patient received SHINGRIX on the left deltoid. The healthcare professional stated that the patient experienced redness and swelling at injection site were approximately 4 inches in diameter. The healthcare professional stated that the patient did not seek medical attention. The healthcare professional declined to provide the patient's date of birth.
This spontaneous report as received from a physician refers to her/his 16 year old female daughter. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported) and concomitantly with a dose of MENACTRA (dose, route of administration, lot # and expiration date were not reported). It was reported that approximately 3 weeks later, the patient developed an "unresolving mass" which the reporter was sure was an abscess. IT was also reported that the patient was in extreme pain. No treatment was given for the adverse events. The outcome of the adverse events was unknown. The relatedness between the adverse events and the vaccination with GARDASIL 9 was not reported. Additional information has been requested.
Developed swollen left gland left axilla on10/18/21.  On 10/28/21 I started with a large abscess left major labia.  On 11/5/21 I saw my physician who did and incision and drained it.  He diagnosed it as a sebaceous cyst.
Myalgia in the arm that vaccine was administered which was more than usual vaccination. No treatment needed. Resolved in a week.
pt had a positive COVID test on 12/16/21 and was in the hospital; dc'd to home on 12/20/21; pt returned to hospital on 12/26/21 with increase in abdominal swelling, abdominal pain, SOB, generalized weakness, anemic; in chronic renal failure, hepatic failure; fluid leaking from abdomen and legs; pt too large for the CT machine; pt passed away in the hospital on 12/29/21
Two to 5 minutes post vax, "whole left side arm, armpit, back to legs hurt, tingling, numb. Felt dizzy 1-2 hours later. Called physician and went to ER. Was given "calming pill" and sent home. Pt did put ice on arm at home. Has redness size of silver dollar and is still sore form shoulder to elbow.
Fainted twice about three mins apart. Sprayed her with cool mist and gave her cold water. VS were taken by was 90/62 pulse was 82. Patient stated she hadn?t eaten anything this morning. Afterwards she was put into the van with air conditioner going and her mom went and got her some fruit from the gas station. Symptoms had resolved by time she went home. She was taken home by mother and was advised to call 911 if any other reactions occur.
fever; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HEADACHE (headache) and CHILLS (chills). On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
I could not raise my arm for 2 days. It started to get a little better by the 3rd day and just plateau at that point for 4 more days. I went to Pharmacy after a week went by and the nurse there told me the shot was given too high as she could see where it was given by the bruise on my arm. She gave me Ibuprofen 800 and said if it did not get any better to get an image of it and gave me a place to go. When I receive the shot the girl had said its bleeding and asked if I was on blood thinners (I am not). She was real nervous and said she must have hit the muscle which at the time I was thinking that was were it supposed to go. I don't think she was sure of what she was doing.
Pt recvd vax & exp severe pain in the arm;pt interrupted sleep @ noc; pt was treated w/anti-inflammatory meds & diazepam; pt was unable to sleep on lt shoulder-pain & difficulty driving a car or any motion that required lt shoulder movement
This case was reported by a pharmacist and described the occurrence of feeling unwell in a 81-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medications included Trazodone, Gabapentin and Omeprazole. On 10 April 2012 (noonish to 14:00) the subject received a dose of BOOSTRIX at 0.5 ml in the left arm. In April 2012, less than one week after vaccination with BOOSTRIX (on or before 12 April 2012), the subject experienced feeling unwell, nausea, heartburn, vomiting (x1) and tiredness. At the time of reporting the events were improved, but not resolved. It was reported that the subject was attempting to make an appointment with her physician regarding these symptoms. Follow-up information was received on 08 May 2012 via pharmacist. The subject was seen by a physician, who felt the reaction was no due to immunization. The subject was reported to have improved, no more nausea. At the time of the report no other details were provided.
Temperature 102.7, starting few hours after DTAP.  Irritable without able to be consoled xx 2 hrs.  Then intermittently irritable, still with fever to 102 after 48 hrs after vaccines.  Some loose stools started.  Consolable, active.
Flu vaccine administered in (L) arm on 9-8-11. Mom reports noticing on 9-9-11 redness, tenderness & swelling around it. Gave ibuprofen & BENADRYL x few days. On 9-15-11 mom checked and noticed redness no swelling. At OV on 9-16 area of redness 4" x 3", no induration, NT. Txed with KEFLEX.
Fever, chills, aches followed by a rash around my neck and torso. The chills woke me up in the middle of the night. They were uncontrollable. My husband took my temperature (101) and gave me Advil.  The fever broke within an hour. The rash didn't appear until the following day. It lasted approximately 2 days. No itching, just a bright red rash. Within 24 hours I felt better but was very tired.
pt recv vax & w/in 15min of vax pt devel an inj site rash that was purple;It spread up arm, around back, & down other arm;ice was applied & the rash resolved in 30min;
Arm rock hard and hot to touch -area measured at 9 x 9 cm at MD. Grew to 12 x 12. Prescribed BENADRYL. Subsiding on 4-24-17.
Seven days post vax, this pt reported a delayed localized reaction of redness and swelling. She recovered.
Severe itching startedted on my palms; Pails of hand extremely red; Welts and hives; Felt like my mody was on fire / burning sensation; A sore arm like getting a flu shot; Swelling of upper airway; Sensation of throat closing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Severe itching started on my palms), ERYTHEMA (Pails of hand extremely red), URTICARIA (Welts and hives), BURNING SENSATION (Felt like my mody was on fire / burning sensation) and PAIN IN EXTREMITY (A sore arm like getting a flu shot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Severe itching startedted on my palms), ERYTHEMA (Pails of hand extremely red), URTICARIA (Welts and hives), BURNING SENSATION (Felt like my mody was on fire / burning sensation), PAIN IN EXTREMITY (A sore arm like getting a flu shot), SWELLING (Swelling of upper airway) and OROPHARYNGEAL DISCOMFORT (Sensation of throat closing). At the time of the report, PRURITUS (Severe itching startedted on my palms), ERYTHEMA (Pails of hand extremely red), URTICARIA (Welts and hives), BURNING SENSATION (Felt like my mody was on fire / burning sensation), PAIN IN EXTREMITY (A sore arm like getting a flu shot), SWELLING (Swelling of upper airway) and OROPHARYNGEAL DISCOMFORT (Sensation of throat closing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   This case was linked to MOD-2021-014232 (E2B Linked Report). This case was linked to MOD-2021-014232 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25 May 2021 contains non-significant information :updated reporters e-mail address. On 26-May-2021: Follow up received on 26 May 2021 contains significant information: Added new events.; Sender's Comments:  MOD-2021-014232:Serious report
Low titers, received a hep B vaccine series when babies; This case was reported by a nurse via call center representative and described the occurrence of therapeutic response decreased in an unspecified number of patients who received Hepatitis B vaccine for prophylaxis.   Co-suspect products included Hepatitis B vaccine for prophylaxis and Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received the 1st dose of Hepatitis B vaccine, the 2nd dose of Hepatitis B vaccine and the 3rd dose of Hepatitis B vaccine. On an unknown date, unknown after receiving Hepatitis B vaccine, Hepatitis B vaccine and Hepatitis B vaccine, the patient experienced therapeutic response decreased. On an unknown date, the outcome of the therapeutic response decreased was unknown.   Additional Information: GSK receipt date: 2-Aug-2022 Reporter's comment: The health care professional also mentioned the most of the nurse staff had low titers of Hepatitis-B, so they decided to restart the series.  They received a Hepatitis-B vaccine series when they were babies. The reporter did not consent to follow-up. The case was linked with case US2022114307, reported by same reporter. Additional supportive information: The patients received Hepatitis-B vaccine series and had low titers of Hepatitis-B, which led to therapeutic response decreased.; Sender's Comments:  US-GSK-US2022114307:Same reporter
Immediately after inoculation: itching, hives, shortness of breath, wheezing.  Treated with IM Epinephrine 0.3mg - symptoms resolved with ED treatment
Woke up with sore, red, swollen and hot arm. Patient also complained of general malaise and dizziness. Patient reported to the pharmacy on 10-2-17 around 5:30pm and arm was still red and swollen to the elbow.
Hives all over her body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives all over her body) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives all over her body). At the time of the report, URTICARIA (Hives all over her body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant and treatment medication information were provided.
slight temperature; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (slight temperature) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PYREXIA (slight temperature) and HEADACHE (headache). In April 2021, PYREXIA (slight temperature) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. Concomitant medications were not provided.
SHINGLES ACUTELY IN THE SAME ARM THAT THE VACCINE WAS ADMINISTERED.
I had a mild case of Granuloma Annulare for many years.  It was under control with 2-4 new lesions on my hands or lower arms.  After the 2nd Covid Vaccine the disease accellerated dramatically with new lesions on upper arms, shoulders and legs.
About a half hour after my vaccination I experienced twitching in my arm, stomach, legs. Thought it would go away. Had extreme twitching in legs like electricity was running throughout every muscle. Lasted about 4 weeks. It was in every muscle of my body. Stomach, legs, arms rear end. Constant all day all night. Never experienced anything like that before. Very uncomfortable and thought I was the only one but have multiple friends who said they experienced the same thing just thought it was low electrolytes. I tried everything to get rid of it. Electrolyte drink, magnesium, potassium, rest. Nothing made it go away. Went to the doctors because of it
Patient was given a full dose of moderna (0.5ml) instead of her 1st booster dose of (0.25ml).
Large red welt below injection site. Severe pain in both arm and leg bones and in joints. Pain lasted all night. Large red welt still there. Sore and itchy.
administrated with engerix-b batch recall; administrated with engerix-b batch recall; This case was reported by a nurse via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B) (batch number CP23D, expiry date 7th December 2023) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 18-APR-2022 Reporter's comments: No patient's identifiers were provided.  The nurse reported that a patient was administrated with Engerix B batch recall for October.  The reporter had been on maternity leave and had just found out about it. No vaccination date was provided. No adverse event was reported. The reporter consented to follow up. Additional Supportive Information: The nurse reported that a patient was administered with Engerix B batch recall, which led to recalled drug administered and drug dispensing error. The Vaccine Administration Facility is the same as primary reporter. This is 1 of the 8 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR068024:Same reporter US-GLAXOSMITHKLINE-US2022066344:Same reporter US-GLAXOSMITHKLINE-US2022AMR068021:Same reporter US-GLAXOSMITHKLINE-US2022AMR068023:Same reporter US-GLAXOSMITHKLINE-US2022AMR068022:Same reporter US-GLAXOSMITHKLINE-US2022AMR068025:Same reporter US-GLAXOSMITHKLINE-US2022AMR068027:Same reporter
Persistent nausea x48 hours, so far. Half dollar size red, warm, swollen area at injection site since 12 hours post injection. No fevers.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Sep2022 as dose 5 (booster), single (Lot number: GJ5372), in left arm and on 06Jun2023 as dose 6 (booster), single (Lot number: GL2042) at the age of 71 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Latex allergy" (unspecified if ongoing); "Breast cancer", start date: 2004 (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19, Paxlovid was administered from 02Nov2023 to 06Nov2023.
This spontaneous report was received from a nurse concerning multiple unspecified patients (demographics unknown). The patient's pertinent medical history and concurrent conditions were not provided. On unspecified dates, the patients were administered doses of improperly stored PNEUMOVAS23 (lot # L013428, expiration date: 30-FEB-2017), (lot # L019835; expiration date: 23-MAR-2017) and (Lot # L040456; expiration date: 10-MAY-2017)(dose and route not provided). Concomitant therapies were not provided. NO adverse effect was reported. It was reported the following temperature excursion to be administered vaccines, high temperature: 49.1 for 1 hour 48 minutes and low temperature: 33.0 F for 35.9 hours. No previous temperature excursion was reported. This is one of several reports received from the same source. Additional information has been requested.
Chilling, shivering, muscle and joint ache, fatigue for about 24 hours, then tapered off. Lymph node under left arm swelled and pain for about a week.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 44 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Aug2021 09:45 (Lot number: EW0187) at the age of 44 years as dose 1, single for Covid-19 immunisation. Relevant medical history included: "Endometriosis" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19: Yes. There were no concomitant medications. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 27Aug2021, outcome "not recovered", described as "Very Stiff neck"; HEADACHE (non-serious) with onset 27Aug2021 10:15, outcome "not recovered", described as "headache"; LYMPHADENOPATHY (non-serious) with onset 27Aug2021 10:15, outcome "not recovered", described as "swollen lymph nodes". Therapeutic measures were not taken as a result of musculoskeletal stiffness, headache, lymphadenopathy. Additional information: On 27Aug2021 10:15 the patient had very stiff neck (within 15 mins) of first shot with headache and swollen lymph nodes. The patient had still have all 3 adverse events bothering her. The patient had to decided to postpone the 2nd shot just in case. The patient did not receive any other vaccine within 4 weeks. The patient did not have any other medications the patient received within 2 weeks of vaccination. The event was non serious and did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. Since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.
Mother noted recurrent lump R lat thigh at site of 3rd Comvax. (Sterile abscess at site L thigh of 2nd Comvax). Recovering.
A non-serious spontaneous report of administered FLUMIST to others and became ill after administering FLUMIST has been received from a nurse concerning herself, an adult female, subsequent to FLUMIST. The patient had a history of low WBC count. No concomitant medications have been reported for this patient. The patient administered FLUMIST on 19-Mar-2012. After administering FLUMIST, the patient became ill. The patient missed one and a half days of work. The outcome of the event administered FLUMIST to others was resolved and that of became ill after administering FLUMIST was unknown.
On 9-5-07 at 07:00am pt noticed swelling on (LT) arm; redness noted at 4:15pm w/ pain in (LT) arm; pt given ice pack at 4:45pm.
My lungs also got congested; fatigue; cough up phlegm; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration, administered on the left arm on 29Mar2021 15:45 at a single dose for COVID-19 immunisation. Medical history included ongoing asthma, high blood pressure and ongoing MS (multiple sclerosis). Concomitant medications included atenolol;chlorthalidone, methylphenidate hydrochloride (RITALIN) and escitalopram oxalate (LEXAPRO). On 29Mar2021 16:30, the patient experienced lungs also got congested after she got the vaccine. They sound like they do after she have had an asthma attack, and she could actually cough up phlegm. She had MS previously and ever since she got the vaccine, her fatigue had increased exponentially and hasn't gotten any better since she got the shot two weeks ago. No treatment was received for the events. The facility where the vaccine was administered was in a school or student health clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. Outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Body core & skull very tender & weak; lower back & neck extreme stiffness 6 weeks acetaminophen & ibuprofen to move, no change; 11/15 Dr. to try to regain neck movement and walking; manipulation and herbal remedies to heal; other symptoms : unable to dress or get into bed without help, had to pick up head with hand to elevate/move head, jaw froze in partial open position not allowing chewing action, incontinence with cough or spasm, unsteady & slow walking with leg sometimes dragging; Still working with Dr. to heal internally and gain function.  Currently in physical therapy to increase range of motion and regain muscle tone. I cannot access your page to give all test results. Basic recovery in progress.